Showing results (41-50 of 267) with videos related to

Sort By:
Pageof 27
Biomedicines|March 29, 2023
COVID-19 in Older Patients: Assessment of Post-COVID-19 SarcopeniaAlmudena López-Sampalo, Lidia Cobos-Palacios, Alberto Vilches-Pérez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 11, 2025
Characterizing Respiratory Virus Infections During the Peri-Engraftment Period of Allogeneic Hematopoietic Cell TransplantJosé Luis Piñana, Clara Martínez-López, Pedro Chorão, et al.
Leukemia & Lymphoma|September 13, 2006
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantationNoemí Puig, Javier de la Rubia, María J Remigia, et al.
Transplantation and Cellular Therapy|January 16, 2023
Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell TransplantationJavier Marco-Ayala, Jaime Sanz, Inés Gómez-Seguí, et al.
The Laryngoscope|July 6, 2004
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynxFernando Rivera, Maria E Vega-Villegas, Marta F López-Brea, et al.
BMJ Open|July 25, 2023
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based studyCarlos Solano, Pedro Castro-Rebollo, Antonio Pérez-Martínez, et al.
HLA|December 28, 2020
Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysisManuel Guerreiro, Dolores Planelles, Cristóbal Aguilar-Gallardo, et al.
Mediterranean Journal of Hematology and Infectious Diseases|February 21, 2012
Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen CombinationRafael Rojas, José R Molina, Isidro Jarque, et al.
Bone Marrow Transplantation|January 3, 2024
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II TrialMónica Cabrero, Lucia López-Corral, Isidro Jarque, et al.
Pharmacoeconomics - Open|October 17, 2018
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in SpainBlanca Boluda, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, et al.
Pageof 27